ebook Munafa Stock Market Course + Intraday & FNO calls  

       

LLY announcements Eli Lilly And Company announcements and dividends declared USA

Eli Lilly And Company Complete list of announcements declared & dividend announcements by Eli Lilly And Company LLY

Eli Lilly And Company LLY listed on USA and deals in Health Care Major Pharmaceuticals

Announcements and dividends declared by Eli Lilly And Company LLY

Eli Lilly buckles under pressure, offers voluntary licence to Natco Pharma
Lily has issued voluntary licenses for Barcitinib to six Indian drug makers besides Natco, these include- Sun Pharma, Cipla, Dr Reddy's, Lupin, Torrent Pharma and MSN Labs. Barcitinib, in combination with Remdesivir, received emergency approval last year f
Announcement as on 17 May 2021

Dr Reddy's inks licensing pact with Eli Lilly for COVID-19 treatment drug
The Hyderabad-based firm said it has entered into a royalty-free, non-exclusive voluntary licensing agreement with Eli Lilly and Company for the manufacture and commercialisation of the drug in India.
Announcement as on 11 May 2021

Eli Lilly signs licensing pact with Cipla, Sun, Lupin for Covid-19 drug
Olumiant, or Baricitinib, is an oral drug developed by US biopharmaceutical major, Incyte Corporation, and licensed to Eli Lilly
Announcement as on 11 May 2021

Eli Lilly inks pacts for Baricitinib with Sun Pharma, Cipla, Lupin for COVID-19 treatment in India
The company "has issued royalty-free, non-exclusive voluntary licenses to established Indian pharmaceutical manufacturers of generic medicines, Cipla, Lupin and Sun Pharmaceutical Industries, who are collaborating with Lilly to accelerate and expand the av
Announcement as on 10 May 2021

India's Cipla to make and sell Eli Lilly's baricitinib to treat COVID-19
Baricitinib has been given restricted emergency use approval by India's drug regulator for use in combination with remdesivir for the treatment of hospitalised COVID-19 adult patients requiring supplemental oxygen, Cipla said in a filing to stock exchanges
Announcement as on 10 May 2021

Announcements by Eli Lilly And Company first page | Next page | Prev page |

LLY Eli Lilly And Company current price & indicator signals

Moving Averages for Eli Lilly And Company

  • 5Day Average: 1144.32
  • 12Day Average: 1120.18
  • 20Day Average: 1086.68
  • 50Day Average: 997.95
  • 100Day Average: 998.85
  • 150Day Average: 1015.01
  • 200Day Average: 958.51

LLY Indicators & signals

Indicator MACD (12,26,9)

1116.74, 1073.54, 41.3
Indicator MACD is in positive zone

Indicator ADX (14)

49.37, 32.86, 11.14
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 60
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of LLY Eli Lilly And Company are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
12 Fri Jun 2026 1133.00 1132.81 to 1169.99 -2.35% 1.28 times
11 Thu Jun 2026 1160.30 1125.64 to 1170.12 2.11% 0.74 times
10 Wed Jun 2026 1136.37 1133.53 to 1166.42 -0.67% 1.41 times
09 Tue Jun 2026 1144.03 1137.75 to 1174.60 -0.34% 1.22 times
08 Mon Jun 2026 1147.88 1143.60 to 1225.00 1.32% 1.22 times
05 Fri Jun 2026 1132.89 1125.64 to 1166.29 0.66% 1.33 times
04 Thu Jun 2026 1125.49 1078.78 to 1140.46 3.9% 1.11 times
03 Wed Jun 2026 1083.23 1053.51 to 1093.28 1.75% 0.67 times
02 Tue Jun 2026 1064.58 1052.15 to 1082.18 -1.63% 0.62 times
01 Mon Jun 2026 1082.17 1071.60 to 1106.17 -2.1% 0.79 times
29 Fri May 2026 1105.37 1089.01 to 1132.66 -1.9% 0.89 times
28 Thu May 2026 1126.80 1092.01 to 1149.10 3.93% 2.41 times

Videos related to: LLY announcements Eli Lilly And Company announcements and dividends declared USA

Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra

Hindi Video What Is Needed To Succeed In Stock Markets

LLY announcements Eli Lilly And Company announcements and dividends declared USA

 

Back to top